Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
People with asthma not at higher risk for poor COVID-19 outcomes, study finds
People with and without asthma have similar risk for COVID-19 outcomes, according to a review of 57 studies published in the Journal of Asthma.
Health care affordability, racial disparities persist in individuals with asthma, COPD
Health insurance coverage losses among patients with asthma and COPD improved after implementation of the Affordable Care Act, but there was no improvement in health care affordability or racial and economic disparities from 1997 to 2018.
Log in or Sign up for Free to view tailored content for your specialty!
Budesonide oral suspension effective against pediatric EoE
Twice-daily budesonide oral suspension, or BOS, improved outcomes in pediatric patients with eosinophilic esophagitis, according to research presented at this year’s virtual American Academy of Allergy, Asthma and Immunology Annual Meeting.
Interdisciplinary approaches help reduce asthma burden
Clinicians are encouraged to team with school employees, asthma educators and patient advocates to improve the health and well-being of patients with asthma, panelists said.
Many patients with peanut allergy first report symptoms in adulthood
Nearly 3% of United States adults self-reported having peanut allergy, with 1.8% “having convincing peanut allergy,” researchers wrote in the Journal of Allergy and Clinical Immunology.
Dupilumab treatment led to clinical remission in patients with uncontrolled asthma
Dupilumab treatment led to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflammation, according to a post hoc analysis of the LIBERTY ASTHMA QUEST study.
Half of patients with sunflower seed allergy experience anaphylaxis
In a recent case series, researchers found that half of patients with a clinical allergy to sunflower seeds experienced anaphylaxis after undergoing allergy tests.
Abrocitinib plus topical therapy effective in adolescents with atopic dermatitis
Abrocitinib combined with a medicated topical therapy was effective, well tolerated and improved quality of life in adolescents with atopic dermatitis, according to phase 3 results from the JADE TEEN Study.
Allergic reactions to COVID-19 vaccines rare, but ‘a lot of uncertainty’ remains
A panel of experts at the virtual American Academy of Allergy, Asthma and Immunology Annual Meeting highlighted current evidence on allergic reactions to available COVID-19 vaccines and how to assess patients who have had a reaction.
Benralizumab eliminates oral corticosteroid use in certain patients with severe asthma
Patients with oral corticosteroid-dependent asthma treated with benralizumab achieved OCS elimination or reduction in those in whom adrenal insufficiency was detected, regardless of baseline eosinophil count, in the PONENTE trial.